bluebird bio Inc (NAS:BLUE)
$ 0.6063 0.0323 (5.63%) Market Cap: 116.86 Mil Enterprise Value: 240.32 Mil PE Ratio: 0 PB Ratio: 0.29 GF Score: 25/100

bluebird bio Inc Launch Call Transcript

Aug 18, 2022 / 12:00PM GMT
Release Date Price: $5.81 (-14.31%)
Operator

Good day, and thank you for standing by. Welcome to the ZYNTEGLO launch call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Courtney O'Leary, Investor Relations. Please go ahead.

Courtney O;Leary
bluebird bio, Inc. - IR Officer

' -

Good morning, everyone, and thank you for joining today's presentation. I am Courtney O'Leary with Investor Relations at bluebird bio. Before I begin, let me review our safe harbor statement.

Today's discussion contains statements that are forward-looking under the Private Securities Litigation Reform Act of 1995, including financial projections in addition to statements of the company's plans, expectations or intentions regarding our commercialization plans following the FDA approval of ZYNTEGLO. Such statements are based on current expectations and assumptions that are subject to risks and uncertainties and involve a number of risk factors that could cause actual results to differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot